サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1754279

糖尿病治療用デバイスの世界市場 - 市場規模、シェア、動向、予測：タイプ別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
糖尿病治療用デバイスの世界市場 - 市場規模、シェア、動向、予測：タイプ別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖尿病治療用デバイスの世界市場規模は2024年に341億9,000万米ドルとなりました。今後、IMARC Groupは、2033年には626億5,000万米ドルに達し、2025年から2033年にかけて6.61%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年の市場シェアは38.6%を超えます。糖尿病の罹患率の上昇、急速な技術進歩、有利な政府イニシアチブの賦課、可処分所得の増加、ビッグデータとアナリティクスの統合、老年人口の増加が市場を推進する主な要因の一部です。

糖尿病治療用デバイスの世界市場の成長は、老人人口の増加、座りがちなライフスタイルの増加、糖尿病患者数の増加につながる食生活の乱れなどが引き金となっています。都市化のペースは肥満の割合の増加とともに上昇を続けています。持続グルコースモニタリング（CGM）システム、スマートインスリンペン、クローズドループインスリンデリバリーなどの先進技術は、患者側のコンプライアンスとアウトカムの向上に貢献しています。糖尿病に対する認識向上と早期診断に向けた政府の取り組みも、特に医療インフラが整備されつつある新興国で市場を活性化させる。例えば、2024年8月、Medtronic社は使い捨てのオールインワンデバイスであるSimplera（TM）CGMのFDA承認を取得し、継続的グルコースモニタリング（CGM）ソリューションを拡大するためのAbbott社との世界パートナーシップを発表しました。さらに、人工知能（AI）とクラウドベースのデータ分析により、より優れた遠隔モニタリング機能を備えた糖尿病管理ソリューションが急増しています。新興経済諸国における可処分所得と医療支出の増加は、先進的な糖尿病治療用デバイスの採用を促進します。償還政策と規制当局の承認もイノベーションと商業化を加速させる。遠隔医療やデジタル糖尿病管理プラットフォームの進歩は、特に慢性疾患の管理において遠隔患者モニタリングがより重要になる中、新たな成長機会をもたらします。

米国の糖尿病治療用デバイス市場シェアは89.5％であるが、これは通院回数を減らす在宅糖尿病管理ソリューションを好む患者の需要が加速しているためです。例えば、2024年8月、Dexcom社は米国初の市販グルコースバイオセンサーであるSteloを発売し、2型糖尿病および糖尿病予備群の患者に対して、処方箋やフィンガースティックなしで24時間365日グルコースに関する洞察を提供しています。さらに、整備されたヘルスケアインフラ、研究施設、確立された償還政策が、新しい糖尿病管理機器やソリューションの使用を支えています。メディケアや民間保険がこのようなデバイスをカバーしているため、特にインスリン依存患者の場合、CGMデバイスの需要は国内で高いです。主要な業界プレイヤーの存在と米国FDAによる定期的な製品承認により、技術開発のペースが速いです。低侵襲で使い勝手が良く、治療効果をサポートする機器に対する消費者の意識の高まりと嗜好が、市場成長の原動力となっています。モバイルアプリやAIベースの糖尿病管理ツールなど、デジタルヘルスソリューションに基づくソリューションの採用拡大が、患者エンゲージメントを強化します。妊娠糖尿病と糖尿病前症の有病率の上昇は、需要量をさらに増幅します。官民パートナーシップと研究助成金は継続的な技術革新を促進し、市場の競争情勢を強化します。

糖尿病治療用デバイス市場動向：

糖尿病罹患率の上昇

糖尿病罹患率の増加は、糖尿病治療用デバイス市場の成長を促進する主要因です。この増加は主に、座りっぱなしの習慣や高糖質・高脂肪食の摂取増加など、様々なライフスタイルの変化によるものです。さらに、糖尿病の患者数が増加するにつれて、効率的な管理とモニタリングツールの必要性がこれまで以上に重要になっています。2021年、世界の成人の糖尿病患者数は約5億3,700万人で、国際糖尿病連合は、この数は今後も増え続け、2045年には7億8,300万人に達すると予測しています。これに伴い、糖尿病治療用デバイスは、グルコース管理の改善、合併症リスクの最小化、緊急医療受診の減少、患者の転帰の向上、迅速な意思決定のためのリアルタイムデータの提供のために広く使用されています。さらに、罹患率の高さは、より高い認識と緊急性をもたらし、それによって技術進歩のペースを加速させるための研究と技術革新の取り組みへのより多くの投資を促し、潜在的な買い手にとって市場をより魅力的なものにしています。

急速な技術進歩

糖尿病治療用デバイス市場は、精度、使いやすさ、利便性を向上させる急速な技術進歩によって形成されています。継続的グルコースモニタリングシステムは、患者の継続的なグルコースプロファイルを観察し、リアルタイムのグルコースモニタリングを提供するCGMを導入しており、治療のカスタマイズやライフスタイルの調整を強化し、この市場の成長にプラスの影響を与えています。業界レポートによると、CGM市場は2028年までに200億米ドルの売上を獲得すると予想されています。さらに、投与量計算機を備えたスマートインスリンペンは、インスリンの実際の投与におけるすべての当て推量を排除することで、高度な技術を組み込んでいるに過ぎず、この市場の成長にも寄与しています。さらに、医療従事者と患者の間でシームレスなデータ共有を可能にする接続機能を備えた革新的なデバイスの市場開拓は、市場成長に好都合です。

有利な政府イニシアチブの発動

公衆衛生政策や政府の取り組みは、糖尿病治療用デバイス市場の成長に重要な役割を果たしています。いくつかの政府は、糖尿病が医療システムに与える負担を認識し、その対策に積極的に取り組んでいます。WHOによると、2021年には、"世界中で4億2,200万人以上がこの病気に苦しんでおり、その経済的負担は世界全体で世界全体で約1兆3,000億米ドルと推定されている"。この点を踏まえると、糖尿病に遭遇するリスクと疾病管理の様々な方法に関して一般大衆に助言するための情報キャンペーンを組織する組織が、マーケティングの成長に寄与しています。さらに、複数の政府による糖尿病治療用デバイスの費用補助のための資金配分の増加により、より幅広い人々がより入手しやすくなっていることも、市場の成長に寄与しています。これに加えて、継続的グルコースモニタリング（CGM）などの高度なデバイスのコストをカバーするためのさまざまな償還制度の導入が、市場の成長に寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の糖尿病治療用デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 血糖値モニタリング（BGM）デバイス
    • 主要セグメント
      • セルフモニタリングデバイス
      • 持続血糖モニタリングデバイス
  • インスリンデリバリーデバイス
    • 主要セグメント
      • ポンプ
      • ペン
      • シリンジ
      • ジェットインジェクター

第7章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • 糖尿病クリニック/センター
  • オンライン薬局
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • 在宅医療
  • 診断センター
  • 外来手術センター

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG（PHC Holdings Corporation）
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players
目次
Product Code: SR112025A5746

The global diabetes care devices market size was valued at USD 34.19 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 62.65 Billion by 2033, exhibiting a CAGR of 6.61% from 2025-2033. North America currently dominates the market, holding a market share of over 38.6% in 2024. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

The growing global market for diabetes care devices is triggered by a geriatric population, increasingly sedentary lifestyle, and poor diets leading to higher levels of diabetes cases. The urbanization pace continues to rise in conjunction with higher rates of obesity. Advanced technology in continuous glucose monitoring (CGM) systems, smart insulin pens, and closed-loop insulin delivery contributes to greater compliance and outcomes from the patients' end. Government efforts toward escalating diabetes awareness and early diagnosis also spur the market, especially in emerging economies with an improving healthcare infrastructure. For instance, in August 2024, Medtronic received FDA approval for its Simplera(TM) CGM, a disposable, all-in-one device, and announced a global partnership with Abbott to expand continuous glucose monitoring (CGM) solutions. Moreover, diabetes management solutions are surged by artificial intelligence (AI) and cloud-based data analytics for better remote monitoring capabilities. Rising disposable income and health care spending in developing economies enhance the adoption of advanced diabetes care devices. Reimbursement policies and regulatory approvals also speed up innovation and commercialization. The advancements in telehealth and in digital diabetes management platforms hold new growth opportunities, especially with remote patient monitoring becoming more critical in the management of chronic diseases.

The U.S. diabetes care devices market share is 89.5% owing to the accelerating demand from patients preferring home-based diabetes management solutions which will reduce their hospital visits. For example, in August 2024, Dexcom launched Stelo, the first over-the-counter glucose biosensor in the U.S., providing 24/7 glucose insights without prescriptions or fingersticks for individuals with Type 2 diabetes and prediabetes. Furthermore, well-developed healthcare infrastructure, research facilities, and established reimbursement policies support the use of novel diabetes management devices and solutions. The demand for CGM devices is high in the country, especially in the case of insulin-dependent patients, since Medicare as well as private insurances cover such devices. The presence of key industry players, combined with regular product approvals by the U.S. FDA, favors fast-paced technological development. Heightened consumer awareness and preference for devices that are minimally invasive, user-friendly, and support therapeutic benefits drive market growth. Greater adoption of digital health solution-based solutions, such as mobile apps and AI-based diabetes management tools, enhance patient engagement. The rising prevalence of gestational diabetes and prediabetes further amplifies the volume of demand. Public-private partnerships and research grants fuel continuous innovation, strengthening the market's competitive landscape.

Diabetes Care Devices Market Trends:

The Rising Incidence of Diabetes

The increasing prevalence of diabetes is a dominant factor fueling the diabetes care devices market growth. This escalation is primarily caused by various lifestyle changes, including sedentary habits and increasing consumption of high-sugar and high-fat diets. Furthermore, as the number of diabetes cases multiplies, the need for efficient management and monitoring tools becomes more critical than ever. In 2021, around 537 million adults worldwide have diabetes, a number that the International Diabetes Federation estimates will continue to rise and reach 783 million by 2045. In line with this, diabetes care devices are widely used to improve glucose management, minimize the risks of complications, reduce emergency healthcare visits, increase patient outcomes, and provide real-time data for quick decision-making. Moreover, the high incidence rates lead to greater awareness and urgency, thereby encouraging more investments in research and innovation efforts to accelerate the pace of technological advancements, making the market even more attractive to potential buyers.

The Rapid Technological Advancements

The diabetes care devices market is being shaped by rapid technological advancements that offer improved precision, ease of use, and convenience. Continuous glucose monitoring systems are introducing CGMs, which observe the continuous glucose profile of a patient and provide real-time glucose monitoring, enhancing treatment customization and lifestyle adjustments that are positively influencing the growth in this market. According to an industry report, the CGM market is expected to capture sales of USD 20 Billion by 2028. Additionally, in smart insulin pens having dose calculators, which are nothing but the incorporation of high sophistication by eliminating all the guesswork in the actual dosing of insulin, is contributing toward this market growth as well. Additionally, the development of innovative devices that are equipped with connectivity features, enabling seamless data sharing between healthcare professionals and patients, is favoring the market growth.

The Imposition of Favorable Government Initiatives

Public health policies and government initiatives play a significant role in the growth of the diabetes care devices market. Several governments are recognizing the burden that diabetes imposes on healthcare systems and are taking proactive measures to address it. According to WHO, in 2021, "over 422 million people across the world were suffering from this disease, which is estimated at around USD 1.3 trillion in its economic burden throughout the world globally." In continuation of this point, the marketing growth is contributed by organizations that organize information campaigns to advise the public in relation to a risk of encountering diabetes and various ways of disease management. Moreover, the increasing allocation of funds by several governments to subsidize the cost of diabetes care devices, making them more accessible to a broader population, is contributing to the market growth. Besides this, the introduction of various reimbursement schemes to cover the cost of advanced devices, such as continuous glucose monitoring (CGMs) is contributing to the market growth.

Diabetes Care Devices Industry Segmentation:

Analysis by Type:

  • Blood Glucose Monitoring (BGM) Devices
    • Self-Monitoring Devices
    • Continuous Glucose Monitoring Devices
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Blood Glucose Monitoring (BGM) leads the market with around 65.8% of market share in 2024. These devices are dominating the market as they are highly affordable, making them accessible to a broader range of consumers. Furthermore, they are designed for user-friendliness, often requiring just a small drop of blood for accurate glucose readings. Additionally, BGM devices offer near-instantaneous results, enabling immediate action if needed, such as adjusting insulin dosage or food intake. Besides this, they are compact and easy to carry, making them convenient for people who are always on the go. This portability ensures that monitoring can happen anytime, anywhere. Moreover, BGM devices are being used for a longer period and enjoy broad acceptance among healthcare providers. In addition, they require minimal upkeep, usually replacement of test strips and occasional calibration, which makes them convenient for long-term use.

Analysis by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

Hospital pharmacies lead the market with around 54.7% of market share in 2024. These are dominating the market as they are considered reliable and trustworthy sources for medical devices, including those for diabetes care. Furthermore, patients admitted for diabetes complications or those visiting for a routine check-up can quickly and conveniently purchase the required devices and supplies from the hospital pharmacy. In addition, they employ well-trained pharmacists who can provide expert advice on device usage, thereby adding an extra layer of reassurance for patients. Besides this, products sold in hospital pharmacies are generally subject to rigorous quality checks, ensuring that patients receive authentic and effective devices. Moreover, they offer a streamlined process for insurance claims and reimbursements, making it easier for patients to offset the costs of their diabetes care devices. Along with this, hospital pharmacies offer a comprehensive range of diabetes care devices, giving patients various options to choose from.

Analysis by End User:

  • Hospitals
  • Homecare
  • Diagnostic Centers
  • Ambulatory Surgery Centers

Hospitals leads the market with around 40.5% of market share in 2024, as they offer a one-stop solution for all medical needs, making it easier for patients to get all their diabetes-related services, including consultations, treatments, and devices. Furthermore, they employ specialists in endocrinology and diabetes care, ensuring that patients receive expert advice and treatment. In addition, hospitals have the resources to handle diabetes-related emergencies, such as diabetic ketoacidosis, which standalone clinics may not be equipped for. Apart from this, hospital-based care is often covered by insurance plans, making it a more accessible option for many patients. Moreover, the sheer number of patients that hospitals serve ensures that they purchase diabetes care devices in bulk, thus contributing to their large share of the market. Along with this, they are subjected to strict quality control standards, which provide assurance of the efficacy and safety of the diabetes care devices used.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 38.6%. The region has one of the highest rates of diabetes in the world, which leads to increased demand for diabetes care devices. Furthermore, the region boasts a well-developed healthcare system with widespread availability of advanced medical technologies, including diabetes care devices. Additionally, the presence of comprehensive insurance plans, which cover diabetes treatment and devices, making it convenient for patients to access the care they need, is positively influencing the market growth. Besides this, North America hosts some of the leading companies in medical device manufacturing that are continuously updating and advancing diabetes care technology. In addition, the escalating awareness about diabetes and its management among regional consumers is acting as another growth-inducing factor. Moreover, the imposition of supportive policies and initiatives by regional governments to combat diabetes and provide access to high-quality treatment is favoring the market growth.

Key Regional Takeaways:

United States Diabetes Care Devices Market Analysis

The U.S. diabetes care devices market is increasing steadily due to the prevalence of diabetes and high healthcare expenditures. According to the CDC, around 37.3 million people in America suffer from diabetes, and this makes 11.3% of the total population in the United States. This raised number is raising the demand for diabetes management products. In 2023, an estimated amount of USD 327 billion were spent on U.S. healthcare on diabetes care, most of which goes into medical devices, including CGMs and insulin pumps. Leading players in this market are Medtronic, Abbott, and Dexcom, which are moving the technologies along to include the integrated insulin delivery systems. The continued efforts towards accessibility and affordability of diabetes devices will further drive the market growth. As the country continues to push for integration of digital health, telemedicine for diabetes care is expected to augment device adoption, ensuring continued momentum in the market.

Europe Diabetes Care Devices Market Analysis

The market for diabetes care devices is increasing in Europe with increasing prevalence of diabetes and increased investment in health. IDF states that 2023 was the year when more than 60 million people were living with diabetes in Europe. Germany and UK are well ahead in using advanced diabetes care devices. These include insulin pens, CGMs, and insulin pumps. Further, cost-effective health care seems to be creating growth opportunities for the European as well as EU-wide markets. There is a wide effort to curb chronic diseases that is also working for the industry's growth. Smart insulin pens, wireless glucose monitoring systems are other innovative products coming from leaders such as Roche and Bayer. The regulation framework in Europe about diabetes care products, safety and effectiveness in treatment, facilitates the innovation in market growth.

Asia Pacific Diabetes Care Devices Market Analysis

Asia Pacific diabetes care devices market is highly growing due to the increasing diabetes rates and geriatric population. IDF reports that more than 170 million people are suffering from diabetes, and the population of China and India is leading in this segment. An industrial report suggests that China's diabetes care market was at USD 4.7 billion in 2023, and considerable investments have been made into the advanced medical devices, which include CGMs and insulin delivery systems. In India, the diabetes care device markets also grow as more emphasis is being put upon cost-effective and affordable solutions. Healthcare infrastructure growth and adoption of digital health solutions have spurred the demand for diabetes devices in this region. Innovation and access to products is also driven through partnerships between international and local players, such as Abbott and Medtronic collaborating in India. Government-backed programs for increasing the accessibility of better diabetes care in the region continue to fuel the growth of this market.

Latin America Diabetes Care Devices Market Analysis

In terms of the high prevalence of diabetes in Latin America, Brazil accounts for over 15.7 million adults who are already affected, a figure provided by the International Diabetes Federation (IDF) of 2021. This explains why the high prevalence of the disease has driven up healthcare costs in the country. As per industrial reports, in 2021, a total of 42.93 billion USD had been allocated toward diabetes care within Brazil. Given the trend this amount is believed to increase profoundly in the forthcoming years, surging to a total of about 48.31 billion in 2030 and 51.44 billion in 2045. In other words, it is directly proportional to increasing disease burden. Moreover, the Brazilian government tries to expand the use of advanced technologies in the treatment of very high medical specialties like insulin pumps, continuous glucose monitors (CGMs), and insulin pens, along with expanding the public knowledge and patient's perception. The overall approach to that is driven by Novo Nordisk, Sanofi, and other key market players with very critical treatment options and increasingly adequate technologies for satisfying the present demand.

Middle East and Africa Diabetes Care Devices Market Analysis

The International Diabetes Federation (IDF) estimates around 73 million adults in the Middle East and North Africa, also known as the MENA region. The statistics show that the prevalence among adults in Saudi Arabia is nearly 17.7%, and about 4.27 million people are diagnosed with diabetes in the country, while South Africa is also the region's 'hot spot'. This boosting trend is due to the growing diabetes care market in the country. Current government action, such as healthcare initiatives that offer cheap access to diabetes care equipment, has been proved to impact the aspect comprehensively. Saudi Arabia has also accentuated the healthcare infrastructure, and campaigns to educate the people about diabetes management. Therefore, the diabetes care market in Saudi Arabia is growing, as demand for insulin pumps and continuous glucose monitoring (CGM) devices is increasing along with other advanced solutions for efficient management of the disease.

Competitive Landscape:

Leadership companies are moving towards bringing next-generation products in the pipeline to market, such as smart insulin pens, CGM integrated devices and much accurate meters for checking the blood sugar. Additionally, major companies are developing partnership arrangements with health-care organisations, IT organizations and sometimes, competitors for designing new devices jointly. Moreover, key companies have developed differentiated product lines which suit emerging geographies where the risk of developing the disease is escalating. They are also integrating digital technologies, such as data analytics and telehealth, into their devices to allow real-time monitoring and data collection, which can be crucial for effective diabetes management. Several companies are investing in education programs and materials to help users understand how to manage diabetes effectively. Along with this, they are leveraging online platforms for direct sales and customer engagement.

The report provides a comprehensive analysis of the competitive landscape in the diabetes care devices market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
  • Becton Dickinson and Company
  • Bionime Corporation
  • Dexcom Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Sinocare Inc.
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.How big is the diabetes care devices market?
  • 2.What is the future outlook of diabetes care devices market?
  • 3.What are the key factors driving the diabetes care devices market?
  • 4.Which region accounts for the largest diabetes care devices market share?
  • 5.Which are the leading companies in the global diabetes care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis